We're developing a novel smart wrist wearable-tech device that reduces hand tremor, specifically Essential Tremor (ET).
Technology allows patients to regain confidence and significantly improves their quality of life. This breakthrough energy system has the potential to address ET and other movement related disorders such as Parkinson's disease (PD) and Dystonia.
Accomplished business leaders with a proven track record with several successful exits.
Allevion Therapeutics was incorporated in 2017 in Delaware and filed multiple patent applications covering broad method and techniques for Class II devices.
Allevion Therapeutics completed seed funding in 2018 followed by recent Series A funding in July 2021